NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	17/07/2020
Target sample size	40
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Zirconium (89Zr) girentuximab Therapeutic category code : 729 Other diagnostic agents (except extracorporeal diagnostic medicines) Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	safety other
Secondary Outcome	safety other

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 99age old
Gender	Both
Include criteria
Exclude criteria